O
Omid Sadr-Azodi
Researcher at Karolinska Institutet
Publications - 40
Citations - 1143
Omid Sadr-Azodi is an academic researcher from Karolinska Institutet. The author has contributed to research in topics: Population & Pancreatitis. The author has an hindex of 14, co-authored 34 publications receiving 867 citations. Previous affiliations of Omid Sadr-Azodi include Uppsala University.
Papers
More filters
Journal ArticleDOI
Influence of Major Postoperative Complications on Health-Related Quality of Life Among Long-Term Survivors of Esophageal Cancer Surgery
TL;DR: The occurrence of postoperative complications exerts a long-lasting negative effect on HRQL in patients who survive 5 years after esophageal cancer surgery, with clinically and statistically significantly deteriorated throughout the follow-up.
Journal ArticleDOI
Hospital and Surgeon Volume in Relation to Survival After Esophageal Cancer Surgery in a Population-Based Study
TL;DR: Because surgeon volume rather than hospital volume independently influences the prognosis after esophageal cancer surgery, centralization of this surgery to fewer surgeons seems warranted.
Journal ArticleDOI
Abdominal and total adiposity and the risk of acute pancreatitis: a population-based prospective cohort study.
TL;DR: Abdominal adiposity, but not total adiposity), is an independent risk factor for the development of acute pancreatitis.
Journal ArticleDOI
Obesity and abdominal aortic aneurysm
TL;DR: An observational cohort study was undertaken to examine the associations between waist circumference as a measure of abdominal adiposity, and between body mass index (BMI) and risk of abdominal aortic aneurysm.
Journal ArticleDOI
Discontinuation of low-dose aspirin therapy after peptic ulcer bleeding increases risk of death and acute cardiovascular events.
Maryam Derogar,Gabriel Sandblom,Gabriel Sandblom,Lars Lundell,Lars Lundell,Nicola Orsini,Matteo Bottai,Yunxia Lu,Omid Sadr-Azodi +8 more
TL;DR: In patients with cardiovascular disease, discontinuation of low-dose aspirin therapy after peptic ulcer bleeding increases risk of death and acute cardiovascular events almost 7-fold.